Wong CK, Yusta B, Koehler JA, Baggio LL, McLean BA, Matthews D, Seeley RJ, Drucker DJ
Important Considerations and Limitations While the potential benefits of GLP-1 microdosing are promising, its crucial to acknowledge the current limitations: Lack of Clinical Guidelines Currently, there are no formal clinical guidelines supporting microdosing protocols
By promoting neuroplasticity and neurotransmitter balance, it contributes to a more balanced and uplifted mood
Huang B, Zhang N, Qiu X, Zeng R, Wang S, Hua M, et al
A 'second wave' of GLP-1 innovation The report describes the 2026 pipeline as reflecting a second wave of innovation focused on improved efficacy, more uses, longer dosing intervals, and broader availability of oral forms
Estimated all-in about $300-400/mo from third-party reports